Trial intelligence / Profile preview

Procollagen-3 Driven Corticosteroids for Persistent ARDS

NCT03371498Phase 3Terminated

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Dec 2018
Primary completion
Nov 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone in acute respiratory distress syndrome (ARDS), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Dec 2018; status: terminated.

02

Drugs

methylprednisolone
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on NCT03371498.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03371498.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call